Table 1 Relationship between CASC9 expression and clinicopathologic parameters of CRC patients
From: LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer
Variables | Patient number (n = 40) | CASC9 levels | P value | Chi-square | |
|---|---|---|---|---|---|
Low (n = 12) | High (n = 28) | ||||
Age(years) | |||||
≥ 65 | 21 | 4 | 17 | 0.112 | 2.525 |
< 65 | 19 | 8 | 11 | ||
Gender | |||||
Female | 17 | 5 | 12 | 0.944 | 0.005 |
Male | 23 | 7 | 16 | ||
Tumor location | |||||
Colon | 30 | 10 | 20 | 0.426 | 0.635 |
Rectum | 10 | 2 | 8 | ||
Tumor size | |||||
≥ 5 cm | 7 | 1 | 6 | 0.318 | 0.998 |
< 5 cm | 33 | 11 | 22 | ||
TNM stage | |||||
I | 9 | 6 | 3 | 0.020 | 7.845 |
II | 9 | 1 | 8 | ||
III | 22 | 5 | 17 | ||
Lymph node metastasis | |||||
Presence | 17 | 4 | 13 | 0.443 | 0.590 |
Absence | 23 | 8 | 15 | ||
Differentiation grade | |||||
Well | 5 | 2 | 3 | 0.159 | 3.673 |
Moderate | 28 | 10 | 18 | ||
Poor | 7 | 0 | 7 | ||